Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterization
Oncoscience · 2014
DOI: 10.18632/oncoscience.100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncoscience, 2014. Verfasst von Liron Nesiel-Nuttman und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Robert H. Smith Institute of Plant Science and Genetics in Agriculture, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Heb…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Robert H. Smith Institute of Plant Science and Genetics in Agriculture, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, ISRAEL.
- School of Nutritional Sciences Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, ISRAEL.
Zitieren
APA
Nesiel-Nuttman, L., Doron, S., Schwartz, B., & Shoseyov, O. (2014). Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterization. Oncoscience. https://doi.org/10.18632/oncoscience.100
Vancouver
Nesiel-Nuttman L, Doron S, Schwartz B, Shoseyov O. Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterization. Oncoscience. 2014. doi:10.18632/oncoscience.100
BibTeX
@article{NesielNuttman2014,
author = {Nesiel-Nuttman, Liron and Doron, Shani and Schwartz, Betty and Shoseyov, Oded},
title = {Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterization},
journal = {Oncoscience},
year = {2014},
doi = {10.18632/oncoscience.100}
}
EUVIMED